Denmark· DK-28104477209
Leuprorelin "Sandoz"
A leuprorelin product containing leuprorelinacetat, registered in Denmark by Sandoz A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Leuprorelin is registered in 13 of 19 countries.
Countries holding a registration under ATC L02AE02 (leuprorelin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Leuprorelin · ATC L02AE02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of leuprorelin costs, country by country.
Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Leuprorelin · price per daily dose (1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$34.21
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- LEUPRORELINACETAT
- Manufacturer
- Sandoz A/S
- Country
- Denmark (DK)
- ATC code
- L02AE02
- ATC class
- Leuprorelin
- Defined daily dose
- 1 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104477209
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
320 interactions on record for leuprorelin.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Leuprorelin · interactions on record
320 records
- 69 severe
- 248 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L02AE02
Leuprorelin, as other registers publish it.
- IcelandCamceviAccord Healthcare S.L.U.
- PolandCamceviAccord Healthcare S.L.U.
- IcelandCamceviAccord Healthcare S.L.U.
- CzechiaCAMCEVIAccord Healthcare S.L.U., Barcelona
- FinlandCAMCEVIAccord Healthcare S.L.U.
- FinlandCAMCEVIAccord Healthcare S.L.U.
- DenmarkCAMCEVIAccord Healthcare S.L.U.
- CzechiaCAMCEVIAccord Healthcare S.L.U., Barcelona
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c834b020-b564-4a38-99fa-ddfa28ac37ba GET /v1/drugs/c834b020-b564-4a38-99fa-ddfa28ac37ba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "implantat, fyldt injektionssprøjte",
"source": "dkma",
"strength": "5 mg",
"auth_role": "CMS",
"dk_drugid": "28104477209",
"substance": "LEUPRORELINACETAT",
"auth_procedure": "MRP",
"in_medicinpriser": true,
"registration_date_serial": "40011"
}See everything about leuprorelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.